518 related articles for article (PubMed ID: 27039136)
1. Novel electrospun nanofibrous matrices prepared from poly(lactic acid)/poly(butylene adipate) blends for controlled release formulations of an anti-rheumatoid agent.
Siafaka PI; Barmbalexis P; Bikiaris DN
Eur J Pharm Sci; 2016 Jun; 88():12-25. PubMed ID: 27039136
[TBL] [Abstract][Full Text] [Related]
2. Investigation of Molecular Weight, Polymer Concentration and Process Parameters Factors on the Sustained Release of the Anti-Multiple-Sclerosis Agent Teriflunomide from Poly(
Bikiaris ND; Koumentakou I; Michailidou G; Kostoglou M; Vlachou M; Barmpalexis P; Karavas E; Papageorgiou GZ
Pharmaceutics; 2022 Aug; 14(8):. PubMed ID: 36015319
[TBL] [Abstract][Full Text] [Related]
3. Controlled release formulations of risperidone antipsychotic drug in novel aliphatic polyester carriers: Data analysis and modelling.
Siafaka PI; Barmpalexis P; Lazaridou M; Papageorgiou GZ; Koutris E; Karavas E; Kostoglou M; Bikiaris DN
Eur J Pharm Biopharm; 2015 Aug; 94():473-84. PubMed ID: 26159838
[TBL] [Abstract][Full Text] [Related]
4. Preparation of New Risperidone Depot Microspheres Based on Novel Biocompatible Poly(Alkylene Adipate) Polyesters as Long-Acting Injectable Formulations.
Nanaki S; Barmpalexis P; Papakonstantinou Z; Christodoulou E; Kostoglou M; Bikiaris DN
J Pharm Sci; 2018 Nov; 107(11):2891-2901. PubMed ID: 30096352
[TBL] [Abstract][Full Text] [Related]
5. Electrospun poly(lactic acid) (PLA)/poly(butylene adipate-co-terephthalate) (PBAT) nanofibers for the controlled release of cilostazol.
Antunes LR; Breitenbach GL; Pellá MCG; Caetano J; Dragunski DC
Int J Biol Macromol; 2021 Jul; 182():333-342. PubMed ID: 33798589
[TBL] [Abstract][Full Text] [Related]
6. Development of poly(lactic acid) nanostructured membranes for the controlled delivery of progesterone to livestock animals.
Oliveira JE; Medeiros ES; Cardozo L; Voll F; Madureira EH; Mattoso LH; Assis OB
Mater Sci Eng C Mater Biol Appl; 2013 Mar; 33(2):844-9. PubMed ID: 25427496
[TBL] [Abstract][Full Text] [Related]
7. Ofloxacin Loaded Electrospun Fibers for Ocular Drug Delivery: Effect of Formulation Variables on Fiber Morphology and Drug Release.
Karataş A; Algan AH; Pekel-Bayramgil N; Turhan F; Altanlar N
Curr Drug Deliv; 2016; 13(3):433-43. PubMed ID: 26521656
[TBL] [Abstract][Full Text] [Related]
8. Selective enzymatic degradation and porous morphology of poly(butylene succinate)/poly(lactic acid) blends.
Shi K; Bai Z; Su T; Wang Z
Int J Biol Macromol; 2019 Apr; 126():436-442. PubMed ID: 30586586
[TBL] [Abstract][Full Text] [Related]
9. Role of specific interfacial area in controlling properties of immiscible blends of biodegradable polylactide and poly[(butylene succinate)-co-adipate].
Ojijo V; Sinha Ray S; Sadiku R
ACS Appl Mater Interfaces; 2012 Dec; 4(12):6690-701. PubMed ID: 23148691
[TBL] [Abstract][Full Text] [Related]
10. A systematic study of captopril-loaded polyester fiber mats prepared by electrospinning.
Zhang H; Lou S; Williams GR; Branford-White C; Nie H; Quan J; Zhu LM
Int J Pharm; 2012 Dec; 439(1-2):100-8. PubMed ID: 23043960
[TBL] [Abstract][Full Text] [Related]
11. Electrospinning of calcium phosphate-poly (d,l-lactic acid) nanofibers for sustained release of water-soluble drug and fast mineralization.
Fu QW; Zi YP; Xu W; Zhou R; Cai ZY; Zheng WJ; Chen F; Qian QR
Int J Nanomedicine; 2016; 11():5087-5097. PubMed ID: 27785016
[TBL] [Abstract][Full Text] [Related]
12. Cyclosporine A Loaded Electrospun Poly(D,L-Lactic Acid)/Poly(Ethylene Glycol) Nanofibers: Drug Carriers Utilizable in Local Immunosuppression.
Sirc J; Hampejsova Z; Trnovska J; Kozlik P; Hrib J; Hobzova R; Zajicova A; Holan V; Bosakova Z
Pharm Res; 2017 Jul; 34(7):1391-1401. PubMed ID: 28405914
[TBL] [Abstract][Full Text] [Related]
13. Poly(L-lactide) and poly(butylene succinate) immiscible blends: from electrospinning to biologically active materials.
Stoyanova N; Paneva D; Mincheva R; Toncheva A; Manolova N; Dubois P; Rashkov I
Mater Sci Eng C Mater Biol Appl; 2014 Aug; 41():119-26. PubMed ID: 24907744
[TBL] [Abstract][Full Text] [Related]
14. Performance of biodegradable microcapsules of poly(butylene succinate), poly(butylene succinate-co-adipate) and poly(butylene terephthalate-co-adipate) as drug encapsulation systems.
Brunner CT; Baran ET; Pinho ED; Reis RL; Neves NM
Colloids Surf B Biointerfaces; 2011 Jun; 84(2):498-507. PubMed ID: 21376545
[TBL] [Abstract][Full Text] [Related]
15. Controlled Release of Linalool Using Nanofibrous Membranes of Poly(lactic acid) Obtained by Electrospinning and Solution Blow Spinning: A Comparative Study.
Souza MA; Oliveira JE; Medeiros ES; Glenn GM; Mattoso LH
J Nanosci Nanotechnol; 2015 Aug; 15(8):5628-36. PubMed ID: 26369129
[TBL] [Abstract][Full Text] [Related]
16. Incorporation of growth factor loaded microspheres into polymeric electrospun nanofibers for tissue engineering applications.
Gungor-Ozkerim PS; Balkan T; Kose GT; Sarac AS; Kok FN
J Biomed Mater Res A; 2014 Jun; 102(6):1897-908. PubMed ID: 23852885
[TBL] [Abstract][Full Text] [Related]
17. Antibacterial electrospun poly(lactic acid) (PLA) nanofibrous webs incorporating triclosan/cyclodextrin inclusion complexes.
Kayaci F; Umu OC; Tekinay T; Uyar T
J Agric Food Chem; 2013 Apr; 61(16):3901-8. PubMed ID: 23590460
[TBL] [Abstract][Full Text] [Related]
18. Release behavior of tetracycline hydrochloride loaded chitosan/poly(lactic acid) antimicrobial nanofibrous membranes.
Jiang S; Lv J; Ding M; Li Y; Wang H; Jiang S
Mater Sci Eng C Mater Biol Appl; 2016 Feb; 59():86-91. PubMed ID: 26652352
[TBL] [Abstract][Full Text] [Related]
19. Nanofibrous matrices of poly(lactic acid) and gelatin polymeric blends for the improvement of cellular responses.
Kim HW; Yu HS; Lee HH
J Biomed Mater Res A; 2008 Oct; 87(1):25-32. PubMed ID: 18080298
[TBL] [Abstract][Full Text] [Related]
20. Electrospun poly(lactic acid)/chitosan core-shell structure nanofibers from homogeneous solution.
Li Y; Chen F; Nie J; Yang D
Carbohydr Polym; 2012 Nov; 90(4):1445-51. PubMed ID: 22944401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
